DR Horton (HO2) Stock Statistics & Valuation Metrics

DR Horton has a market cap or net worth of CHF34.24B. The enterprise value is $46.36B.

DR Horton has ― shares outstanding. The number of shares has decreased by -2.65% in one year.

DR Horton’s return on equity (ROE) is 0.15 and return on invested capital (ROIC) is 10.09%.

The current PE Ratio of DR Horton is 13.7. DR Horton’s PEG ratio is -0.75.

In the last 12 months, DR Horton had revenue of 34.25B and earned 3.59B in profits. Earnings per share was 11.62.

In the last 12 months, operating cash flow was 3.65B and capital expenditures -154.40M, giving a free cash flow of 3.50B billion.

DR Horton pays an annual dividend of ―, resulting in a dividend yield of ―

DR Horton upcoming earnings date is Jul 21, 2026, Before Open (Confirmed).

DR Horton as a current ratio of 17.39, with Debt / Equity ratio of 27.78%

In the past 12 months, DR Horton has paid 1.12B in taxes.

DR Horton EV to EBITDA ratio is 11.43, with an EV/FCF ratio of 16.85.

DR Horton has CHF1.92B in cash and marketable securities with CHF6.56B in debt, giving a net cash position of -CHF4.65B billion.

Gross margin is 22.80%, with operating margin of 12.92%, and net profit margin of 10.47%.

The average price target for DR Horton is CHF132.05, which is 11.43% higher than the current price. The consensus rating is Hold